CD8A and neoplasm: reported decreased ITGB7 expression in tumor-infiltrating CD8+T cells, with higher expression correlating with improved survival in colorectal cancer patients, suggesting its role in sustaining antitumor immune cell infiltration and inhibiting tumor progression (49).